Chemotherapy and interferon-α treatment of Erdheim-chester disease

Pediatric Blood and Cancer

Volumn 55, Issue 4, 2010, Pages 745-747

  Jeon, In Sang ^a   Lee, Sang Seon ^a   Lee, Min Kyung ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Erdheim Chester disease; Histiocytosis; Interferon

Indexed keywords

ALPHA INTERFERON; CD68 ANTIGEN; FLUORODEOXYGLUCOSE F 18; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINBLASTINE;

ADOLESCENT; ARTICLE; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CELL INFILTRATION; CELL PROLIFERATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ERDHEIM CHESTER DISEASE; FEMALE; HISTIOCYTE; HUMAN; IMMUNOHISTOCHEMISTRY; LEG PAIN; LOW BACK PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS PAIN SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SPINDLE CELL;

ADOLESCENT; ERDHEIM-CHESTER DISEASE; FEMALE; HUMANS; INTERFERON-ALPHA; METHOTREXATE; PREDNISONE; VINBLASTINE;

EID: 77957059556     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22636     Document Type: Article

References (13)

1. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al. Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine 1996; 75: 157-169.
2. Kushihashi T, Munechika H, Sekimizu M, et al. Erdheim-Chester disease involving bilateral lower extremities: MR features. Am J Roentgenol 2000; 174: 875-876.
3. Haroche J, Amoura Z, Dion E, et al. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: Report of 6 new cases and a literature review. Medicine 2004; 83: 371-392.
4. Clerico A, Ragni G, Cappelli C, et al. Erdheim-Chester disease in a child. Med Pediatr Oncol 2003; 41: 575-577.
5. Luft T, Luetjens P, Hochrein H, et al. IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. Int Immunol 2002; 14: 367-380.
6. Luft T, Pang KC, Thomas E, et al. Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 1998; 161: 1947-1953.
7. Braiteh F, Boxrud C, Esmaeli B, et al. Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha. Blood 2005; 106: 2992-2994.
8. Suzuki HI, Hosoya N, Miyagawa K, et al. Erdheim-Chester disease: Multisystem involvement and management with interferon-alpha. Leuk Res 2010; 34: e21-24.
9. Tran TA, Fabre M, Pariente D, et al. Erdheim-Chester disease in childhood: A challenging diagnosis and treatment. J Pediatr Hematol Oncol 2009; 31: 782-786.
10. Al-Quran S, Reith J, Bradley J, et al. Erdheim-Chester disease: Case report, PCR-based analysis of clonality, and review of literature. Mod Pathol 2002; 15: 666-672.
11. Jendro MC, Zeidler H, Rosenthal H, et al. Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil. Clin Rheumatol 2004; 23: 52-56.
12. Brown RE. Interferon-alpha therapy, protein kinase C-alpha and Langerhans cell histiocytosis. Med Pediatr Oncol 2003; 41: 63-64.
13. Haroche J, Amoura Z, Trad SG, et al. Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: Results in eight patients. Arthritis Rheum 2006; 54: 3330-3336.